Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 8, 2026, 2:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 121–137 of 137 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: No Intervention-Clinical Assessments only Clear all

Conditions: Hemodynamic Monitoring
Interventions: Noninvasive Hemodynamic Monitoring System; Device
Lead sponsor: AcQumen Medical, Inc.; Industry
Eligibility: 2 Months to 95 Years
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Riverside, Connecticut

Conditions: Traumatic Brain Injury (TBI), Post Traumatic Stress Disorder (PTSD)
Interventions: Driving Behavior Interview, Clinical Driving Assessment, Propensity for Angry Driving Scale, Community Integration Questionnaire, Satisfaction with Life, Fitness-to-Drive Screening Measure (FTDS), Simulated Driving Evaluation, Driving Safety Education, Occupational Therapy Driving Intervention (OT-DI), On-road driving test, Driving triggers evaluation; Behavioral · Other · Procedure
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 85 Years
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 2
States / cities: Gainesville, Florida

Conditions: Atrial Fibrillation, Atrial Fibrillation, Persistent, Atrial Fibrillation Paroxysmal, Arrhythmia, Arrhythmias, Cardiac, Atrial Flutter, Atrial Fibrillation, Paroxysmal or Persistent, Atrial Arrhythmia, Atrial Tachycardia
Interventions: Electrographic Flow (EGF) mapping and ablation of EGF-identified sources of Atrial Fibrillation, Electrographic Flow (EGF) mapping (no ablation); Device
Lead sponsor: Cortex; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 15
States / cities: Birmingham, Alabama • Phoenix, Arizona • Redwood City, California + 11 more

Conditions: ST Elevation Myocardial Infarction, Cardiovascular Diseases
Interventions: No intervention, Interview, Survey; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 473 participants
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Healthy, Autonomic Nervous System Diseases, Lymphatic Diseases, Somatic Dysfunction, Chapman Reflex Points
Interventions: Chapman Reflex Point Examination; Procedure
Lead sponsor: The Touro College and University System; Other
Eligibility: 18 Years and older
Enrollment: 101 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Colon Cancer Screening
Interventions: FITx3 intervention and CRC education, Colorectal Cancer (CRC) education alone; Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 45 Years to 75 Years · Male only
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Hepatocellular Carcinoma
Interventions: TheraSphere Y-90 glass microsphere therapy, Durvalumab (Imfinzi) immunotherapy, Tremelimumab immunotherapy; Device · Drug
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 12
States / cities: San Diego, California • San Francisco, California • Washington D.C., District of Columbia + 7 more

Conditions: Hematopoietic Stem Cell Transplant, Pediatric Cancer, Deconditioning
Interventions: Exercise regimen; Behavioral
Lead sponsor: Phoenix Children's Hospital; Other
Eligibility: 4 Years to 21 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Sudden Infant Death, Sudden Unexplained Infant Death
Interventions: ISA-MI, Standard of Care (SOC); Behavioral · Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 3 Days to 75 Years
Enrollment: 350 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Oppositional Defiant Disorder, Conduct Disorder, Attention Deficit Hyperactivity Disorder
Interventions: Booster Treatment, No-Booster, No intervention, Treatment As Usual; Behavioral · Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 6 Years to 11 Years
Enrollment: 254 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2009
U.S. locations: 2
States / cities: Cincinnati, Ohio • Pittsburgh, Pennsylvania

Conditions: Liver Biopsy
Interventions: biopsy; Diagnostic Test
Lead sponsor: AdventHealth; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Heart Failure
Interventions: Acorai Sensor Data Collection (ASDC) system 1.0 - Phase 1, Acorai Sensor Data Collection (ASDC) system 1.0 - Phase 2; Device
Lead sponsor: Acorai AB; Industry
Eligibility: 18 Years and older
Enrollment: 1,602 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 10
States / cities: Conway, Arkansas • Little Rock, Arkansas • Jacksonville, Florida + 6 more

Conditions: Sickle Cell Disease
Interventions: Blood draw, Nasopharyngeal wash; Other
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 1 Year and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Microvascular Disease, Retinal Disease
Interventions: XyCAM CRE Imaging; Device
Lead sponsor: Stuart Terry Eye Associates; Other
Eligibility: 21 Years to 100 Years
Enrollment: 350 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: High-Risk Multidisciplinary Care, Clinical Decision Support, Artificial Intelligence-Assisted Care, Telemedicine
Interventions: Gemini 3.1 Pro with Safety Prompt, ANCHOR Clinical AI Verification Layer (with Gemini 3.1 Pro); Behavioral
Lead sponsor: Waymark; Industry
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Alzheimer Disease
Interventions: Challenge A - low calorie Ensure®, Challenge B - Ensure® plus ketone esters (KE), PET Scan, Cognitive Testing - FCSRT, Story Recall, BVRT, CogState One Card Learning; Dietary Supplement · Procedure · Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 50 Years to 85 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: End Stage Renal Disease
Interventions: Patient-Guided, Educator-Guided; Other
Lead sponsor: The Methodist Hospital Research Institute; Other
Eligibility: 18 Years to 74 Years
Enrollment: 558 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Los Angeles, California

Search by objective public record fields.

Evaluation of the UltraTrac System as a Non-Invasive Monitor of Hemodynamic Parameters

Effectiveness of a Driving Intervention on Safe Community Mobility for Returning Combat Veterans

RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.

RUral dispaRities in prehospitAL STEMI

Prevalence of Chapman Reflex Points in Medical Students and Their Association With Visceral Symptoms

A Study of Using Social Networks to Encourage Three Peers to Complete Screening for Colorectal Cancer

TheraSphere With Durvalumab and Tremelimumab for HCC

Benefits of Intrahospital Exercise Program in Pediatric HSCT

Improving Pediatrician Counseling About Infant Safe Sleep Using the Electronic Medical Record

Resources to Enhance the Adjustment of Children (REACH)

Endoscopic Ultrasound vs Percutaneous Route for Liver Biopsy

Acorai Machine Learning Generalization (MLG) Study

A New Reagent Assay Examining Natural Parvovirus B19 Infection in Sickle Cell Disease

Collecting Data on Retinal Blood Blood Flow and Blood Vessel Shape/Appearance Using an Investigational Device, XyCAM CRE, and to Then Compare Those Images With Images Collected From a Patient's Routine Clinical Examination.

ANCHOR Validation Trial in High-Risk Multidisciplinary Care

The Brain Ketone Body Challenge Imaging Study

Explore Transplant at Home: Improving Low-Income ESRD Patients' Transplant Knowledge